Institut de Cardiologie de Montreal

Montreal, Quebec H1T 1C8

0 studies enrolling now · 14 studies all time

What they study most

Acute Coronary Syndrome, Angioplasty, Transluminal, Percutaneous Coronary, Aortic Valve Disease, Aortic Valve Disorder, Atrial Fibrillation, Atrial Flutter, Cardiovascular Disease, Coronary Artery Disease, Heart Arrhythmias, Heart Failure, Mitral Regurgitation, Sudden Cardiac Death

Studies at this site

• Cephea Early Feasibility Study — Recruiting now
• A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Running, not enrolling
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Study of Ponsegromab in People With Heart Failure — Stopped early
• Trifecta™ GT Post Market Clinical Follow-up — Completed
• Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP — Completed
• Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS — Completed
• Clinical Trial for the Prevention of Vasovagal Syncope — Completed
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed
• Safety of Sports for Patients With Implantable Cardioverter-Defibrillators — Completed
• The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention — Completed
• A Phase II/III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Flutter — Completed
• Phase III Tolerance and Efficacy Study of RSD1235 in Patients With Atrial Fibrillation — Completed
• Phase II Study To Evaluate The Safety and Efficacy of Hemoglobin Raffimer in Patients Undergoing First Time CABG Surgery — Paused